chr5-157463195-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001099287.2(NIPAL4):c.139C>T(p.Gln47*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001099287.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NIPAL4 | NM_001099287.2 | c.139C>T | p.Gln47* | stop_gained | Exon 2 of 6 | ENST00000311946.8 | NP_001092757.2 | |
NIPAL4 | NM_001172292.2 | c.139C>T | p.Gln47* | stop_gained | Exon 2 of 5 | NP_001165763.2 | ||
NIPAL4 | XM_011534552.2 | c.-171C>T | 5_prime_UTR_variant | Exon 2 of 6 | XP_011532854.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln109*) in the NIPAL4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NIPAL4 are known to be pathogenic (PMID: 15317751, 17557927). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with NIPAL4-related conditions. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.